Eric F
2010-08-25 20:16:30
Speaking from experience here, this drug is already in the middle of an FDA/Medicare fiasco, and has been for years. Even though it is made primarily for colon cancers, it is an extremely inexpensive way to treat macular degeneration due to the way it interacts with vascular tissue (and only costs $250 per injection due to the dosing). However, the company that makes it also make’s something they market specifically for macular degeneration called Lucentis which costs $2000 per injection, and apparently doesn’t even work as well! And guess which one Medicare approves? (which of course causes private health insurers to follow suit with….)
